| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.07 |